We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EYE or CLX: Which Is the Better Value Stock Right Now?
Read MoreHide Full Article
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of National Vision (EYE - Free Report) and Clorox (CLX - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
National Vision has a Zacks Rank of #1 (Strong Buy), while Clorox has a Zacks Rank of #3 (Hold) right now. Investors should feel comfortable knowing that EYE likely has seen a stronger improvement to its earnings outlook than CLX has recently. But this is just one factor that value investors are interested in.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
EYE currently has a forward P/E ratio of 21.39, while CLX has a forward P/E of 23.34. We also note that EYE has a PEG ratio of 1.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CLX currently has a PEG ratio of 2.95.
Another notable valuation metric for EYE is its P/B ratio of 1.01. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, CLX has a P/B of 88.57.
These metrics, and several others, help EYE earn a Value grade of B, while CLX has been given a Value grade of D.
EYE sticks out from CLX in both our Zacks Rank and Style Scores models, so value investors will likely feel that EYE is the better option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
EYE or CLX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of National Vision (EYE - Free Report) and Clorox (CLX - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
National Vision has a Zacks Rank of #1 (Strong Buy), while Clorox has a Zacks Rank of #3 (Hold) right now. Investors should feel comfortable knowing that EYE likely has seen a stronger improvement to its earnings outlook than CLX has recently. But this is just one factor that value investors are interested in.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
EYE currently has a forward P/E ratio of 21.39, while CLX has a forward P/E of 23.34. We also note that EYE has a PEG ratio of 1.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CLX currently has a PEG ratio of 2.95.
Another notable valuation metric for EYE is its P/B ratio of 1.01. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, CLX has a P/B of 88.57.
These metrics, and several others, help EYE earn a Value grade of B, while CLX has been given a Value grade of D.
EYE sticks out from CLX in both our Zacks Rank and Style Scores models, so value investors will likely feel that EYE is the better option right now.